6505--Metformin IR Tablets

Closed Pre-Solicitation Posted

This opportunity was awarded. See the award notice from , or the latest solicitation from .

Solicitation number
36E79725R0041
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0041 for Metformin HCL IR Tablets, targeting multiple federal agencies including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The procurement is unrestricted and will be conducted electronically through SAM.gov, with the solicitation expected to be issued on April 14, 2025, and proposals due by April 29, 2025. Offerors must provide a unique National Drug Code (NDC) number and are required to use only their own label on the product, with no overlabeling permitted. The contract will be awarded to a responsible offeror capable of providing an uninterrupted supply of the contracted items. Vendors should direct any questions to Teresa Hussain at Teresa.Hussain@va.gov, and all documentation will be available exclusively through electronic download on SAM.gov.

The contract will be structured for an initial one-year period with four additional pre-priced one-year option periods, distributed through VA Pharmaceutical Prime Vendor Programs. No specific set-aside designations are indicated, meaning all responsible sources may submit an offer. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC code 6505 for Drugs and Biologicals. While specific award values are not disclosed, the solicitation suggests VA intends to award a single contract to the most qualified vendor. The procurement will cover comprehensive pharmaceutical needs across multiple federal healthcare systems, indicating a potentially significant volume of Metformin HCL IR Tablets to be supplied during the contract period.

Notice text

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0041 for an unrestricted procurement for Metformin HCL IR Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DOD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).

VA will award one contract to the responsible offeror(s) who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Programs.

Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.

Solicitation # 36E79725R0041 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about April 14, 2025, with a tentative closing date of April 29, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to Teresa.Hussain@va.gov

Files

File Type Posted
36E79725R0041_1.docx DOCX document

Notice history

Notice Type Posted
6505--Metformin HCL IR Tablets Effective 08/11/2025 - 08/10/2026 Award Award Notice
6505--Metformin IR Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
6505--Department of Veterans Affairs Pharmaceutical Industry Day NAICS 325412 Veterans Integrated Service Network 12 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity